Verma et. al.; Gene therapy—promises, problems and prospects, 1997, Nature vol. 389: 238-242.* |
Dang et. al.; Gene Therapy and Translational Cancer Research, 1999, Clinical Cancer Research, vol. 5: 471-474.* |
Miller et. al.; Targeted vectors for gene therapy, 1995, FASEB J. 9: 190-199.* |
Deonarian: Ligand-targeted receptor-mediated vectors for gene delivery, 1998, Exp. Opin. Ther. Patents 8: 53-69.* |
Huber et. al.; Metabolism of 5-fluorocytosine to 5-fluiorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase, 1994, Proc.* |
Greco et al., Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives, 2001, Journal of Cellular Physiology, vol. 187, pp. 22-36.* |
Xu et al., Strategies for enzyme/prodrug cancer therapy, 2001, Clinical Cancer Research, vol. 7, pp. 3314-3324.* |
Ngo et al., Computational complexity, protein structure prediction and the levinthal paradox, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 491-495.* |
Rudinger, Characteristics of the amino acids as components of a peptide hormone sequence, 1976, Peptide Hormones, pp. 1-7.* |
Brzobohaty et al., Release of active cytokine by a b-glucosidase localized to the maize root meristem, 1993, Science, vol. 262.* |
Blakey, Enzyme Prodrug therapy of cancer, 1997, Exp. Opin. Ther. Patents, pp. 965-977.* |
Denny, William A., “Prodrug strategies in cancer therapy,” Eur. J. Med. Chem., (2001) 36, 577-595. |
Dubowchik, Gene J., et al., “Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs,” Pharmacology & Therapeutics, (1999), 83, 67-123. |
Marais, Richard, et al., “A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy,” Nature Biotechnology, (Dec. 1997), vol. 15, 1373-1377. |
Marais, Richard, et al., “Gene-directed Enzyme Prodrug Therapy with a Mustard Prodrug/Carboxypeptidase G2 Combination,” Cancer Research, (Oct. 15, 1996), 56, 4735-4742. |
Niculescu-Duvaz, et al., “Antibody-directed enzyme prodrug therapy (ADEPT): a review,” Elsevier Science B.V., Advanced Drug Delivery Reviews, (1997) 26, 151-172. |
Abraham, Ralph, et al., “Conjugates of COL-1 Monoclonal Antibody and β-D-Galactosidase Can Specifically Kill Tumor Cells by Generation of 5-Fluorouridine from the Prodrug β-D-Galactosyl-5-Fluorouridine,” Cell Biophysics, vol. 24/25 pp. 127-133 (1994). |
Bakina, E., et al., “Intensely cytotoxic anthracycline prodrugs: galactosides,” Anti-Cancer Drug Design, Dec. 1999, vol. 14(6), pp. 507-515, abstract. |
Denny, W.A., et al., “The design of selectively-activated anti-cancer prodrugs for use in antibody-directed and gene-directed enzyme-prodrug therapies,” J. Pharm. Pharmacol. 1998, vol. 50(4), pp. 387-394, abstract. |
Farquhar, D., et al., “Antitumor galactoside prodrugs,” Proc. Annu. Meet. Am. Assoc. Cancer Research, (1997), vol. 38, p. A4121, Abstract. |
Farquhar, D., et al. “Antitumor galactoside prodrugs,” Proc. Annu. Meet. Am. Assoc. Cancer Research Annual Meeting 1997, vol. 38, pp. 613-614, Abstract. |
Marini F., et al., “E. coli LacZ as a suicide gene for anticancer prodrug activation,” Proc. Annu. Meet. Am. Assoc. Cancer Research 1997, vol. 38, p. A2294, abstract. |
Alexander, R.P., Beeley, N.R.A., O'Driscoll, M., O'Neill, F.P., Millican, T.A., Pratt, A.J., Willenbrock, F.W., “Cephalosporin Nitogen Mustard Carbamate Prodrugs for ADEPT”, Tet. Lett. 32:3269-3272 (1991). |
Barnes, D., Sato, G., “Media for Growth of Cultured Cells in Serum-Free Medium”, Anal. Biochemistry 102:255-270 (1980). |
Blakey, D.C., Valcaccia, B.E., East, S., Wright, A.F., Boyle F.T., Springer C.J., Burke, P.J., Melton, R.G., Bagshawe, K.D., “Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug”, Cell Biophys., 22(1-3):1-8 (1993). |
Blazquez, M.A., Soowal, L.N., Lee, I., Weigel, D., “LEAFY expression and flower initiation in Arabidopsis” Development 124: 3835-3844 (1997). |
Brown, F.J., Andisik, D.W., Bernstein, P.R., Bryant, C.B., Ceccarelli, C., Damewood J.R. Jr., Edwards, P.D., Earley, R.A., Feeney, S., Green, R.C., Gomes, B., Kosmider, B.J., Krell, R.D., Shaw, A., Steelman, G.B., Thomas, R.M., Vacek, E.P., Veale, C.A., Tuthill, P.A., Warner, P., Williams, J.C., Wolanin, D.J., Woolson, S.A., “Design of orally active, non-peptidic inhibitors of human leukocyte elastase”, J. Med. Chem., 37(9):1259-61 (1994). |
Chen, S.H., Kosai, K.I., Xu, B., Pham-Nguyen, K., Contant, C., Finegold, M.J., Woo, S.L.C., “Combination Suicide and Cytokine Gene Therapy for Hepatic Metastases of Colon Carcinoma: Sustained Antitumor Immunity Prolongs Animal Survival”, Cancer Research 56:3758-3762 (1996). |
Chiang, L.C., Silnutzer, J., Pipas, J.M., Barnes, D.W., “Serum-Free Cell Culture for Growth of NIH3T3 and 10T1/2 Mouse Embryo Fibroblast Cell Lines, SV40 Virus Propagation, and Selection of SV40 Transfromed Cells”, in Methods for Serum-Free Culture of Epithelial and Fibroblastic Cells, pp. 265-276, Alan R. Liss, Inc. publ. New York, NY (1984). |
Colledge, W.H., Evans, M.J., “Cystic fibrosis gene therapy”, British Med. Bull. 51(1): 82-90 (1995). |
Culver, K.W., Vickers, T.M., Lamsam, J.L., Walling, H.W., Seregina, T., “Gene Therapy for solid tumors”, British Medical Bulletin 51(1):192-204 (1995). |
Delia, D., Aiello, A., Lombardi, L., Pelicci, P.G., Grignani, F., Grignani, F., Formelli, F., Menard, S., Costa, A., Veronesi, U., Pierotti, M.A., “N-(4-Hydroxyphenyl)retinamide Induces Apoptosis of Malignant Hemopoietic Cell Lines Including Those Unresponsive to Retinoic Acid”, Cancer Res., 53(24):6036-41 (1993). |
Eicher, S.A., Lotan, R., “Differential Effects of Retinoic Acid and N-(4-hydroxyphenyl)retinamide on Head and Neck Squamous Cell Carcinoma Cells”, Laryngoscope 106: 1471-1475 (1996). |
Fanjul, A.N., Delia, D., Pierotti, M.A., Rideout, D., Qiu, J., Pfahl, M., “4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors”, J. Biol. Chem. 271(37):22441-22446 (1996). |
Fichera, A., Michelassi, F., Arenas, R.B., “Selective Expression of carcinoembryonic antigen promoter in cancer cell lines: targeting strategy for gene therapy in colorectal cancer”, Dis. Colon Rectum, 41(6): 747-754 (1998). |
Freeman, S.M., Abboud, C.N., Wartenby, K.A., Packman, C.H., Koeplin, D.S., Moolten, F.L., Abraham, G.N., “The “Bystander Effect”: Tumor Regression When a Fraction of Tumor Mass Is Genetically Modified”, Cancer Research 53:5274-5283 (1993). |
Hall, Simon J., “Adenovirus-Mediated Herpes Simplex Virus Thymidine Kinase Gene and Ganciclovir Therapy Leads to Systemic Activity Against Spontaneous and Induced Metastasis in an Orthotopic Mouse Model of Prostate Cancer,” Int. J. Cancer, 70:183-187 (1997). |
Hanessian, S., Wang, J., “Design and synthesis of a cephalosporin-carboplatinum prodrug activatable by b-lactamase”, Can. J. Chem. 71:896-905 (1992). |
Hempel, F.D., Weigel, D., Mandel, M.A., Ditta, G., Zambryski, P.C., Feldman, L.J., Yanofsky, M.F., “Floral determination and expression of floral regulatory genes in Arabidopsis”, Develoment 124:3845-3853 (1997). |
Hu, H.M., Urba, W.J., Fox, B.A., “Gene-Modified Tumor Vaccine with Therapeutic Potential Shifts Tumor-Specific T Cell Response from a Type 2 to a Type 1 Cytokine Profile”, J. Immunol., 161(6):3033-41 (1998). |
Huennekens, F.M., “Development of Methotrexate a-Peptides as Prodrugs for Activation by Enzyme-Monoclonal Antibody Conjugates”, Advan. Enzyme Regul. 37:77-92 (1997). |
Illek, B., Fischer, H., Machen, T.E., “Genetic Disorders of Membrane Transport II. Regulation of CFTR by small molecules including HCO3-”, Amer. J. Physiol. 275 (Gastrointest. Liver Physiol. 38): G1221-G1226 (1998). |
Isaacs, S.T., Shen, C.K.J., Hearst, J.E., Rapoport, H., “Synthesis and Characterization of New Psoralen Derivatives with Superior Photoreactivity with DNA and RNA”, Biochemistry 16(6): 1058-1064 (1977). |
Jiang, C., Fang, S.L., Xiao, Y.F., O'Connor, S.P., Nadler, S.G., Lee, D.W., Jefferson, D.M., Kaplan, J.M., Smith, A.E., Cheng, S.H., “Partial restoration fo cAMP-stimulated CFTR chloride channel activity in deltaF508 cells by deoxyspergualin”, Amer. J. Physiol. 275 (Cell. Physiol. 44): C171-C178 (1998). |
Kerr, M.W., “Bioactivated Herbicides” in The Society for Experiemental Biology Serminar Series, No. 38:199-210 (1989). |
Krapcho, A.P., Getahun, Z., Avery, K.L., Vargas, K.J., Hacker, M.P., “Synthesis and Antitumor Evaluations of Symmetrically and Unsymmetrically Substituted 1,4-Bis[(aminoalkyl)amino]anthracene-9,10-diones and 1,4-Bis[(aminoalkyl)amino]-5,8-dihydroxyanthracene-9,10-diones”, J. Med. Chem. 34:2373-2380 (1991). |
Krasnow, M.A., Cumberledge, S., Manning, G., Herzenberg, L.A., Nolan, G.P., “Whole Animal Cell Sorting of Drosophila Embryos”, Science 251:81-85 (1991). |
Lapetina, E.G., Reep, B., Ganong, B.R., Bell, R.M., “Exogenous sn-1,2-Diacylglycerols Containing Saturated Fatty Acids Function as Bioregulators of Protein Kinase C in Human Platelets”, J. Biol. Chem., 260(3):1358-61 (1985). |
Lichtenhaler, F.W., Sanemitsu, Y., Nohara, T., “Synthesis of 5′-O-Glycosyl-ribo-nucleosides”, Angew. Chem. Int. Ed. Engl. 17(10): 772-774 (1978). |
Lira, S.A., Kinloch, R.A., Mortillo, S., Wassarman, P.M., “An upstream region of the mouse ZP3 gene directs expression of firefly luciferase specifically to growing oocytes in transgenic mice”, Proc. Natl. Acad. Sci. USA 87: 7215-7219 (1990). |
Marth, C., Bock, G., Daxenbichler, G., “Effect of 4-Hydroxyphenylretinamide and Retinoic Acid on Proliferation and Cell Cycle of Cultured Human Breast Cancer Cells”, J. Natl. Cancer Inst. 75(5):871-875 (1985). |
Meyer, D.L., Jungheim, L.N., Mikolajczyk, S.D., Shepherd, T.A., Starling, J.J., Ahlem, C.N., “Preparation and Characterization of a b-Lactamase-Fab' Conjugate for the Site-Specific Activation of Oncolytic Agent”, Bioconjugate. J. 3(1):42-48 (1992). |
Moon, R.C., Thompson, H.J., Beddi, P.J., Grubbs, C.J., Gander, R.J., Newton, D.L., Smith, J.M., Phillips, S.L., Henderson, W.R., Mullen, L.T., Brown, C.C., Sporn, M.B., “N-(4-Hydroxyphenyl)retinamide, A New Retinoid for Prevention of Breast Cancer in the Rat”, Cancer Res. 39: 1339-1346 (1979). |
Mullen, C.A., Kilstrup, M., Blaese, R.M., “Transfer of the bacterial gene for cytosine deaminase to mamallian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system” Proc. Natl. Acad. Sci. USA 89:33-37 (1992). |
Nabel, E.G., Plautz, G., Nabel, G.J., “Site Specific Gene Expression in Vivo by Direct Gene Treansfer into the Arterial Wall”, Science 249:1285-1288 (1990). |
Nabel, G.J., Nabel, E.G., Yang, Z.Y., Fox, B.A., Plautz, G.E., Gao, X., Huang, L., Shu, S., Gordon, D., Chang, A.E., “Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans”, Proc. Natl. Acad. Sci. USA 90:11307-11311 (1993). |
Peters, M.T., Brigham, K.L., King, G.A., Meyrick, B.O., Gao, X., Stecenko, A.A., “Optimization of cationic liposome-mediated gene transfer to human bronchial epithelial cells expressing wild-type or abnormal cystic fibrosis transmembrane conductance regulator (CFTR)” Exp. Lung Res., 25(3):183-97 (1999). |
Raz, E., Zlorarnik, G., Tsien, R.Y., Driever, W., “beta-Lactamase as a marker for gene expression in live zebrafish embryos”, Devel. Biol. 203(2): 290-294 (1998). |
Ring, CJA, et al., Suicide gene expression induced in tumor cells transduced with recombinant adenoviral, retroviral and plasmid vectors containing the ERBB2 promoter, Gene Therapy, 3:1094-1103 (1996). |
Rosenfeld, M.E., Wang, M., Siegal, G.P., Alvarez, R.D., Mikheeva, G., Krasnykh, V., Curiel, D.T., “Adenoviral-mediated delivery of herpes simplex virus thymidine kinase results in tumor reduction and prolonged survival in a SCID mouse model of human ovarian carcinoma”, J. Mol. Med. 74:455-462 (1996). |
Sanes, J.R., Rubenstein, J.L.R., Nicolas, F., “Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos”, EMBO J. 5(12): 3133-3142 (1986). |
Schneider, M., Ow, D.W., Howell, S.H., “The in vivo pattern of firefly luciferase expression in transgenic plants”, Plant Mol. Biol. 14: 935-947 (1990). |
Senter, P.D., Schreiber, G.J., Hirshberg, D.L., Ashe, S.A., Hellstrom, K.E., Hellstrom, I., “Enhancement of the in Vitro and in Vivo Antitumor Activities of Phosphorylated Mitomycin C and Etoposide Derivatives by Monoclonal Antibody-Alkaline Phosphatase Conjugates”, Cancer Res. 49:5789-5792 (1989). |
Smith, O., “Pain-Killer Genes”, Science 284:1634 (1999). |
Stalker, D.M., McBride, K.E., Malyj, L.D., “Herbicide Resistance in Transgenic Plants Expressing a Bacterial Detoxification Gene”, Science 242: 419-423 (1988). |
Tiraby, Michele, et al. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine, FEMS Microbiology Letters 167:41-49 (1998). |
Touchette, N., “Cancer Researchers Seek Therapies to Zero in on Tumors”, J. NIH Res. 4:64-65 (1992). |
Umeda, Y., Moriguchi, M., Kuroda, H., Nakamura, T., Iinuma, H., Takeuchi, T., Umezawa, H., “Synthesis and Antitumor Activity of Spergualin Analogues”, J. Antibiotics 38(7):886-898 (1985). |
Watanabe, K.A., Matsuda, A., Halat, M.J., Hollenberg, D.H., Nisselbaum, J.S., Fox, J.J., “Nucleosides. 114.5′-O-Glucuronides of 5-Fluorouridine and 5-Fluorocytidine. Masked Precursors on Anticancer Nucleosides”, J. Med. Chem. 24: 893-897 (1981). |
Westerfield, M., Wegner, J., Jegalian, B.G., DeRobertis, E.M., Puschel, A.W., “Specific activation of mammalian HOX promoters in mosaic transgenic zebrafish”, Genes & Devel. 6:591-598 (1992). |
Wilson, S.P., Yeomans, D.C., Bender, M.A., Lu, Y., Goins, W.F., Glorioso, J.C., “Antihyperalgesic effects of infection with a preproenkephalin encoding herpes virus”, Proc. Natl. Acad. Sci. USA 6:3211-3216 (1999). |
Worley, C.K., Ling, R., Callis, J., “Engineering in vivo instability of firefly luciferase and Escherichia coli b-glucuronidase in higher plants using recognition elements from the ubiquitin pathway”, Plant Mol. Biol. 37: 337-347 (1998). |
Yee, Douglas, et al. “Adenovirus-Mediated Gene Transfer of Herpes Simplex virus Thymidine Kinase in an Ascites Model of Human Breast Cancer,” Human Gene Therapy, 7:1251-1257 (Jun. 20, 1996). |
Zee-Cheng, R.K.Y., Cheng, C.C., “Antineoplastic Agents. Structure-Activity Relationship Study of Bis(substituted aminoalkylamino)anthraquinones”, J. Med. Chem. 21(3): 291-294 (1978). |
Zlorarnik, G., Negulescu, P.A., Knapp, T.E., Mere, L., Burres, N., Feng, L., Whitney, M., Roemer, K., Tsien, R.Y., “Quantitation of Transcription and Clonal Selection of Single Living Cells with b-Lactamase as Reporter”, Science 279: 84-87 (1998). |